Scientists at the University of Oxford demonstrate an approach to interpreting how materials interact with polarized light, ...

Perhaps one of the most famous experiments in physics has been giving us the wrong message all these years. For nearly two ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Non-terrestrial networks, combined with early 6G research, demand test equipment capable of handling extreme parameters and ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Over the past decades, engineers have introduced numerous technologies that rely on light and its underlying characteristics. These include photonic and quantum systems that could advance imaging, ...

This study presents an elliptical retarder model, enhancing polarization analysis and offering a robust framework for ...

Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...

Marvel Phase 6 is running full steam ahead, and this could be the biggest MCU chapter ever. With two new Avengers movies, a Spider-Man film, and much more besides, we're in for a treat with this era ...

Could the first confirmed signal from an extraterrestrial source be less a hello than a goodbye? Astrophysicist David Kipping ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

Background Western diet and associated production of secondary bile acids (BAs) have been linked to the development of ...